Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amneal Pharmaceuticals, Inc.
IPO Date: January 1, 1900
Sector: Healthcare
Industry: Biotech
Market Cap: $3.22B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.15 | 2.47%
Avg Daily Range (30 D): $0.14 | 1.36%
Avg Daily Range (90 D): $0.12 | 1.39%
Institutional Daily Volume
Avg Daily Volume: .4M
Avg Daily Volume (30 D): 1.27M
Avg Daily Volume (90 D): 1.25M
Trade Size
Avg Trade Size (Sh.): 148
Avg Trade Size (Sh.) (30 D): 90
Avg Trade Size (Sh.) (90 D): 95
Institutional Trades
Total Inst.Trades: 1,754
Avg Inst. Trade: $1.59M
Avg Inst. Trade (30 D): $2.78M
Avg Inst. Trade (90 D): $2.35M
Avg Inst. Trade Volume: .19M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.74M
Avg Closing Trade (30 D): $3.22M
Avg Closing Trade (90 D): $2.7M
Avg Closing Volume: 208.53K
   
News
Oct 9, 2025 @ 1:31 PM
Teva, Viatris On Investor Watch As White House Spa...
Source: Vandana Singh
Oct 2, 2025 @ 1:06 PM
3 Lesser-Known Healthcare Names With Major Upside ...
Source: Nathan Reiff
Sep 26, 2025 @ 12:00 PM
Amneal Announces BLA Submission of Biosimilar Cand...
Source: Amneal Pharmaceuticals
Sep 12, 2025 @ 8:00 AM
Ophthalmic Packaging Market Worth USD 23.65 Billio...
Source: Towards Packaging
Aug 27, 2025 @ 12:00 PM
Binge Eating Disorders Global Market Research Repo...
Source: Researchandmarkets.Com
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $.01 $.07 $.04
Diluted EPS $.01 $.07 $.04
Revenue $ 2.85B $ 724.51M $ 695.42M
Gross Profit $ 1.07B $ 286.25M $ 255.89M
Net Income / Loss $ 51.24M $ 35.61M $ 24.62M
Operating Income / Loss $ 376.32M $ 111.37M $ 100.35M
Cost of Revenue $ 1.78B $ 438.26M $ 439.53M
Net Cash Flow $ 34.05M $ 15.28M $ -50.03M
PE Ratio 1,050.00    
Splits
Aug 26, 2013:   1:25